VVV ELZONRIS

Serial Number 99206080
638

Registration Progress

Application Filed
May 28, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

VVV ELZONRIS

Basic Information

Serial Number
99206080
Filing Date
May 28, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
638
Status Date
Jul 9, 2025
Application
Pending
Classes
005

Rights Holder

Stemline Therapeutics, Inc.

03
Address
750 Lexington Avenue, 11th Floor
New York, NY 10022

Ownership History

Stemline Therapeutics, Inc.

Original Applicant
03
New York, NY

Stemline Therapeutics, Inc.

Original Applicant
03
New York, NY

Legal Representation

Attorney
Maury M Tepper, III

Application History

10 events
Date Code Type Description
Jul 9, 2025 DOCK D ASSIGNED TO EXAMINER
Jul 9, 2025 DOCK D ASSIGNED TO EXAMINER
Jul 1, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 1, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 1, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 1, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
May 28, 2025 MAFR O APPLICATION FILING RECEIPT MAILED
May 28, 2025 NWAP I NEW APPLICATION ENTERED
May 28, 2025 MAFR O APPLICATION FILING RECEIPT MAILED
May 28, 2025 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Anti-cancer preparations
First Use Anywhere: Dec 21, 2018
First Use in Commerce: Dec 21, 2018

Additional Information

Design Mark
The mark consists of the text “ELZONRIS” preceded by the stylized design of a circle open at the top with a series of three, two-dimensional inverted “V” shapes extending downwards and into the middle of the circle.
Design Mark
The mark consists of the text “ELZONRIS” preceded by the stylized design of a circle open at the top with a series of three, two-dimensional inverted “V” shapes extending downwards and into the middle of the circle.

Classification

International Classes
005

USPTO Documents

Click to view cached USPTO documents for this trademark

Only administrators can request new documents from USPTO